Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differential effects of sertraline and cognitive behavioural therapy on behavioural inhibition in patients with obsessive compulsive disorder.
Reid JE, Pellegrini L, Drummond L, Varlakova Y, Shahper S, Baldwin DS, Manson C, Chamberlain SR, Robbins TW, Wellsted D, Fineberg NA. Reid JE, et al. Among authors: drummond l. Int Clin Psychopharmacol. 2024 Apr 25. doi: 10.1097/YIC.0000000000000548. Online ahead of print. Int Clin Psychopharmacol. 2024. PMID: 38568112
Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder.
Fineberg NA, Baldwin DS, Drummond LM, Wyatt S, Hanson J, Gopi S, Kaur S, Reid J, Marwah V, Sachdev RA, Pampaloni I, Shahper S, Varlakova Y, Mpavaenda D, Manson C, O'Leary C, Irvine K, Monji-Patel D, Shodunke A, Dyer T, Dymond A, Barton G, Wellsted D. Fineberg NA, et al. Int Clin Psychopharmacol. 2018 Nov;33(6):334-348. doi: 10.1097/YIC.0000000000000237. Int Clin Psychopharmacol. 2018. PMID: 30113928 Free PMC article. Clinical Trial.
Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders.
Fineberg NA, Hollander E, Pallanti S, Walitza S, Grünblatt E, Dell'Osso BM, Albert U, Geller DA, Brakoulias V, Janardhan Reddy YC, Arumugham SS, Shavitt RG, Drummond L, Grancini B, De Carlo V, Cinosi E, Chamberlain SR, Ioannidis K, Rodriguez CI, Garg K, Castle D, Van Ameringen M, Stein DJ, Carmi L, Zohar J, Menchon JM. Fineberg NA, et al. Among authors: drummond l. Int Clin Psychopharmacol. 2020 Jul;35(4):173-193. doi: 10.1097/YIC.0000000000000314. Int Clin Psychopharmacol. 2020. PMID: 32433254 Free PMC article. Review.
Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology.
Castle D, Beilharz F, Phillips KA, Brakoulias V, Drummond LM, Hollander E, Ioannidis K, Pallanti S, Chamberlain SR, Rossell SL, Veale D, Wilhelm S, Van Ameringen M, Dell'Osso B, Menchon JM, Fineberg NA. Castle D, et al. Among authors: drummond lm. Int Clin Psychopharmacol. 2021 Mar 1;36(2):61-75. doi: 10.1097/YIC.0000000000000342. Int Clin Psychopharmacol. 2021. PMID: 33230025 Free PMC article.
Effects of exercise on obsessive-compulsive disorder symptoms: a systematic review and meta-analysis.
Bottoms L, Prat Pons M, Fineberg NA, Pellegrini L, Fox O, Wellsted D, Drummond LM, Reid J, Baldwin DS, Hou R, Chamberlain S, Sireau N, Grohmann D, Laws KR. Bottoms L, et al. Among authors: drummond lm. Int J Psychiatry Clin Pract. 2023 Sep;27(3):232-242. doi: 10.1080/13651501.2022.2151474. Epub 2022 Dec 21. Int J Psychiatry Clin Pract. 2023. PMID: 36541901
A Randomized Trial Directly Comparing Ventral Capsule and Anteromedial Subthalamic Nucleus Stimulation in Obsessive-Compulsive Disorder: Clinical and Imaging Evidence for Dissociable Effects.
Tyagi H, Apergis-Schoute AM, Akram H, Foltynie T, Limousin P, Drummond LM, Fineberg NA, Matthews K, Jahanshahi M, Robbins TW, Sahakian BJ, Zrinzo L, Hariz M, Joyce EM. Tyagi H, et al. Among authors: drummond lm. Biol Psychiatry. 2019 May 1;85(9):726-734. doi: 10.1016/j.biopsych.2019.01.017. Epub 2019 Jan 30. Biol Psychiatry. 2019. PMID: 30853111 Free PMC article. Clinical Trial.
Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis of randomised controlled trials.
Reid JE, Laws KR, Drummond L, Vismara M, Grancini B, Mpavaenda D, Fineberg NA. Reid JE, et al. Among authors: drummond l. Compr Psychiatry. 2021 Apr;106:152223. doi: 10.1016/j.comppsych.2021.152223. Epub 2021 Feb 2. Compr Psychiatry. 2021. PMID: 33618297 Free article. Review.
Obsessive-compulsive symptoms and the Covid-19 pandemic: A rapid scoping review.
Grant JE, Drummond L, Nicholson TR, Fagan H, Baldwin DS, Fineberg NA, Chamberlain SR. Grant JE, et al. Among authors: drummond l. Neurosci Biobehav Rev. 2022 Jan;132:1086-1098. doi: 10.1016/j.neubiorev.2021.10.039. Epub 2021 Nov 2. Neurosci Biobehav Rev. 2022. PMID: 34740755 Free PMC article. Review.
Commentary on the article: "Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial" Foa EB et al., JAMA Psychiatry. 2022;79(3):193-200 (1).
Fineberg NA, Hollander E, Grant JE, Chamberlain SR, Drummond LM, Pellegrini L, Laws KR, Wellsted D, Reid J, Nezgovorova V, Baldwin DS. Fineberg NA, et al. Among authors: drummond lm. Compr Psychiatry. 2022 Jul;116:152323. doi: 10.1016/j.comppsych.2022.152323. Epub 2022 Apr 28. Compr Psychiatry. 2022. PMID: 35537294 Free article. Clinical Trial. No abstract available.
205 results